http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101686872-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-10 |
| filingDate | 2015-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101686872-B1 |
| titleOfInvention | New compounds having anti-inflammatory and anti oxidatant activity through TLR4 binding competition with LPS and medical use thereof |
| abstract | The present invention relates to a novel compound having antioxidant and anti-inflammatory effects which inhibit the activity of macrophages through competitive binding to LPS, and medicinal uses thereof, and the compounds according to the present invention have antioxidant and anti-inflammatory activity Metabolic disease or cardiovascular disease through competitive binding to LPS by competitive binding to TLR4-MD2, particularly by preventing LPS from binding to LPS in the prevention or treatment of geriatric diseases, It can be used as a health food. |
| priorityDate | 2014-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 283.